Stentz FB, Brewer A, Wan J, Garber C, Daniels B, Sands C, Kitabchi AE
And that craving seems to be quieted or suppressed, he said
CagriSema produced mean weight loss of 13.7% at 68 weeks compared to 3.4% with placebo, with an on-treatment estimate of 15.7%
Efficacy and Safety of Resmetirom, a Selective Thyroid Hormone Receptor- Agonist, in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review and Meta-Analysis
Hayes LN, Severance EG, Leek JT, Gressitt KL, Rohleder C, Coughlin JM et al
In fact, up to 50% of people on these treatments report feeling sick